Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.048 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |